Showing results (2091-2100 of 3,272) with videos related to

Sort By:
Pageof 328
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 13, 2016
Exceptional patients and communication in cancer care-are we missing another survival factor?Moshe Frenkel, Joan C Engebretson, Sky Gross, et al.
Plos Pathogens|July 13, 2016
Trypanosoma brucei Co-opts NK Cells to Kill Splenic B2 B CellsDeborah Frenkel, Fengqiu Zhang, Patrick Guirnalda, et al.
Cell Transplantation|September 22, 2017
Magnetic Enhancement of Stem Cell-Targeted Delivery into the Brain Following MR-Guided Focused Ultrasound for Opening the Blood-Brain BarrierWei-Bin Shen, Pavlos Anastasiadis, Ben Nguyen, et al.
Radiology|March 31, 2005
Pulsed high-intensity focused ultrasound enhances systemic administration of naked DNA in squamous cell carcinoma model: initial experienceKristin M Dittmar, Jianwu Xie, Finie Hunter, et al.
Gene Therapy|April 15, 2005
Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubblesG Korpanty, S Chen, R V Shohet, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|November 14, 2017
Effects of Microcystis on development of early life stage Japanese medaka (Oryzias latipes): Comparative toxicity of natural blooms, cultured Microcystis and microcystin-LRSpencer R Saraf, Amy Frenkel, Matthew J Harke, et al.
Physical Chemistry Chemical Physics : PCCP|December 21, 2017
A comprehensive study of catalytic, morphological and electronic properties of ligand-protected gold nanoclusters using XPS, STM, XAFS, and TPD techniquesQiyuan Wu, Jiajie Cen, Yue Zhao, et al.
Physical Review Letters|January 7, 2003
Direct separation of short range order in intermixed nanocrystalline and amorphous phasesAnatoly I Frenkel, Alexander V Kolobov, Ian K Robinson, et al.
Schizophrenia Bulletin|January 1, 1995
Reanalysis of SCOR and anxiety measures in the Israeli High-Risk StudyS Kugelmass, N Faber, L J Ingraham, et al.
American Journal of Clinical Oncology|June 6, 2008
Phase I dose escalation study with irinotecan, capecitabine, epirubicin, and granulocyte colony-stimulating factor support for patients with solid malignanciesCarlos R Becerra, Udit N Verma, Hia T Tran, et al.
Pageof 328